Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Oppenheim Website

Joost J. Oppenheim, M.D.

Selected Publications

1)  Chen X, Yang Y, Zhou Q, Weiss JM, Howard OZ, McPherson JM, Wakefield LM, Oppenheim JJ.
Effective chemoimmunotherapy with anti-TGFß antibody and cyclophosphamide in a mouse model of breast cancer.
PLoS ONE. 9: e85398, 2014.
2)  Zhou Q, Hu Y, Howard OM, Oppenheim JJ, Chen X.
In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.
Cytokine. 65: 56-64, 2014.
3)  Hu Y, Xiao H, Shi T, Oppenheim JJ, Chen X.
Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4(+)  Foxp3(+) regulatory T cells.
Immunology. 142: 193-201, 2014.
4)  Chen X, Oppenheim JJ.
Th17 cells and Tregs: unlikely allies.
J. Leukoc. Biol. [Epub ahead of print], 2014.
5)  Yang D, Wei F, Tewary P, Zack Howard OM, Oppenheim JJ.
Alarmin-induced cell migration.
Eur. J. Immunol. 43: 1412-8, 2013.
6)  Stagliano KE, Oppenheim JJ.
DEXterity of tolerogenic APCs.
Eur. J. Immunol. 43: 38-41, 2013.
7)  Yoshimura T, Howard OM, Ito T, Kuwabara M, Matsukawa A, Chen K, Liu Y, Liu M, Oppenheim JJ, Wang JM.
Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells.
PLoS ONE. 8: e58791, 2013.
8)  Tewary P, de la Rosa G, Sharma N, Rodriguez LG, Tarasov SG, Howard OM, Shirota H, Steinhagen F, Klinman DM, Yang D, Oppenheim JJ.
ß-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-a production by human plasmacytoid dendritic cells, and promote inflammation.
J. Immunol. 191: 865-74, 2013.
9)  Chen X, Wu X, Zhou Q, Howard OM, Netea MG, Oppenheim JJ.
TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment.
J. Immunol. 190: 1076-84, 2013.
10)  Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, Horwood N, Nanchahal J.
Alarmins: awaiting a clinical response.
J. Clin. Invest. 122: 2711-9, 2012.
Click Here to View Expanded Bibliography.

This page was last updated on 5/14/2014.